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Abstract
A recent comparison of two rhesus cytomegalovirus (RhCMV) genomes revealed that the region at the right end of the UL genome component
(ULb′) undergoes genetic alterations similar to those observed in serially passaged human cytomegalovirus (HCMV). To determine the coding
content of authentic wild-type RhCMV in this region, the ULb′ sequence was amplified from virus obtained from naturally infected rhesus
macaques without passage in vitro. A total of 24 open reading frames (ORFs) potentially encoding N99 amino acid residues were identified, 10 of
which are related to HCMV ORFs and 15 to previously listed RhCMV ORFs. In addition, the analysis revealed a cluster of three novel alpha
chemokine-like ORFs, bringing the number of predicted alpha chemokine genes in this region to six. Three of these six genes exhibit a high level
of sequence diversity, as has been observed for the HCMV alpha chemokine gene UL146.
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lovirus (HCMV) are ubiquitous throughout their host popula-
tions (rhesus macaques and humans, respectively) and cause
subclinical, persistent, lifelong infections in healthy individuals
(Barry and Chang, 2007; Britt, 2007). In immune compromised
individuals, however, CMVs can cause significant morbidity
and mortality. RhCMV and HCMV genomes are largely
colinear, although species-specific genes are present in each.
The region at the right end of the UL genome component (ULb′)
in HCMV contains multiple open reading frames (ORFs)
encoding cell tropism and immune modulating functions that
may be mutated or deleted during passage of clinical isolates in
vitro (Cha et al., 1996; Dolan et al., 2004). Recent work has
demonstrated that the corresponding region in RhCMV under-
goes similar changes, thus the genetic content of ULb′ in wild-
type virus is presently undefined (Hansen et al., 2003; Rivailler
et al., 2006).⁎ Corresponding author. Center for Comparative Medicine, University of
California, Davis, County Rd. 98 & Hutchison Dr., Davis, CA 95616, USA.
E-mail address: pabarry@ucdavis.edu (P.A. Barry).
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doi:10.1016/j.virol.2007.10.040The prototypical RhCMV strain 68-1 (Asher et al., 1974) has
been annotated as containing 230 ORFs of N99 amino acid
residues (aa) (Hansen et al., 2003) and the 180.92 strain as
containing 258 ORFs ranging in size from 21 to 2178 aa
(Rivailler et al., 2006). The analytical approaches taken were not
the same in both studies, and the number and locations of
genuine protein-coding ORFs remain unclear. There are also
differences between the two strains, since the genome of 180.92
is approximately 5 kbp smaller than that of 68-1. The majority of
the potential coding differences are located in a 15 kbp region
that corresponds to ULb′ in HCMV, and it appears that, as in
HCMV, RhCMV ULb′ is labile during passage in vitro.
Comparisons of 68-1 and 180.92 have led to a model in which
the sequence of wild-type RhCMVwas proposed to contain four
contiguous genomic segments designated A, B, C, andD (Fig. 1)
(Rivailler et al., 2006). The sequence of 180.92 lacks segments C
andD, while that of 68-1 lacks segment A, and segments B andC
are inverted relative to segment D. In order to characterize the
coding capacity of ULb′ in wild-type RhCMV that has not been
passaged in vitro and test this proposed model, DNA from
RhCMV naturally circulating at the California National Primate
Fig. 1. Genomic arrangement of the ULb′ region of wild-type RhCMV circulating in the rhesus macaque colony at the CNPRC (accession number EF990255) relative
to the ULb′ regions of RhCMV 68-1 (AY186194) and 180.92 (DQ120516). The regions of overlap with 68-1 and 180.92 are listed by the corresponding numbering
system for each RhCMV variant. The proposed structure of the consensus RhCMVULb′ region (segments A –D) proposed by Rivailler et al. (2006) is shown together
with the novel segment (E) found in RhCMV CNPRC. Predicted ORFs within ULb′ region of RhMV CNPRC are presented, all of which are on the complementary
strand. Shaded ORFs in segment E indicate those ORFs not present in either 68-1 or 180.92. ORFs homologous to HCMVORFs are designated by ‘UL’. ORFs without
homologues in HCMVare designated with the naming scheme of Hansen et al (indicated by ‘rh’). Boxes joined by a horizontal line represent proposed exons. rh161,
annotated in 68-1, is listed here as rh161.2. rh161.1 is named to reflect the sequence identity with the previously named rh161 ORF (see text for details). RhUL146a
and 146b are named to reflect their alpha chemokine-like sequence homology, similar to RhUL146. It should be noted that the 5′ point of overlap with 68-1 and 180.92
is imprecise (see text for details). †: The proposed RhUCMV L130 ORF based on a possible spliced product of the rh157.4 and RhCMV UL130 ORF (annotated in
180.92; see Fig. 3 and text for details).
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seropositive animals, and the ULb′ sequence of RhCMV was
determined.
Results
A 13,066 bp sequence (46% G+C) of RhCMVCNPRC
spanning the region of non-colinearity between the 68-1 and
180.92 genomes was assembled from multiple overlapping
amplicons (GenBank Accession Number EF990255). The
sequence included 714 and 470 bp of overlap with both
genomes at its 5′ and 3′ ends, respectively (Fig. 1). The 5′ end of
the sequence begins upstream of UL128, and the 3′ end of the
sequence maps downstream of the rh167 ORF. The 5′ end of the
sequence contains a 22 bp sequence (CCGTCTCTCAGAC-
CAAATTTAC) directly repeated 30 times, with 27 copies
identical in sequence. This sequence does not match any known
transcription factor binding sites (data not shown). A variant
sequence in the overlapping region of the 68-1 genome
(CCGTCTCTCAGACTAATTTGAC) is present as 19 imperfect
direct repeats, and another variant sequence (CCGGGTCTCA-
GACCAATTTTAC) is present as 15 imperfect direct repeats in
180.92 (underlined nucleotides represent differences from
RhCMVCNPRC). Due to the number and degeneracy of the
repeats in 68-1 and 180.92, there was some uncertainty about the
exact extent of overlap with the 5′ end of the RhCMVCNPRC
sequence.
Analysis of RhCMVCNPRC largely validated the model for
the ULb′ region (Rivailler et al., 2006). A total of 24 ORFs of
N99 aa were identified in both strands, 15 of which (transcribed
right to left, Fig. 1) are present in either or both of 68-1 and180.92. Ten of these 15 ORFs have HCMV sequence homo-
logues. Six of the identified ORFs, oriented from left to right
(not shown in Fig. 1) were considered unlikely to represent
authentic coding regions since they are not conserved in other
primate cytomegalovirus genomes and exhibit no significant
similarity to other proteins. The remaining 3 ORFs (RhUL146a,
RhUL146b, and rh161.1 in segment E; Fig. 1) are absent from
68-1 and 180.92. Each of these novel genes potentially encodes
a protein that is related (31–57% identity) to cellular alpha
chemokines (Fig. 2).
Alpha chemokines contain a characteristic motif (CXC), and
activation of target cells is dependent on the three residues (ELR)
immediately preceding this motif (Clark-Lewis et al., 1991). Two
of the novel RhCMVCNPRC ORFs (RhUL146b and rh161.1)
contain this (ELRCXC) or a very similar motif (ELYCXC or
EQRCXC, respectively). The third ORF (RhUL146a) contains
another variant ([H/Y]PRCXC). RhUL146a is proposed to
contain an intron since protein sequence homology to alpha
chemokines is present in two discontinuous regions separated by
appropriately located splice sites (Fig. 2C). The proposed protein
product of this gene exhibits strong structural homology to alpha
chemokines based on Phyre analysis. Although BLAST analysis
did not identify any viral protein sequences homologous to
RhUL146a, CCMV but not HCMV also contains an ORF,
UL146A, in the same general region within ULb′ (Davison et al.,
2003). CCMVUL146A is related to the tandemly arrayedUL146
ORF, which is homologous to HCMV UL146, an alpha
chemokine (Penfold et al., 1999).
The presence of the three novel RhCMV genes and the
genomic arrangement of ULb′ were confirmed using viral
DNA amplified from two additional non-co-housed macaques
Fig. 2. Protein alignments of (A) RhUL146, (B) RhUL146a, (D) RhUL146b, (E) rh161.1, and (F) rh161.2 of RhCMV68-1, RhCMVCNPRC, and RhCMV22659.
RhCMVCNPRC protein sequences isolated from different macaques are indicated as CNPRC1, CNPRC2, or CNPRC3. If two variants were isolated from the same
macaque, they are designated as var1 and var2. The proposed exon/intron boundaries for RhUL146a are also shown (C). Predicted signal peptide cleavage sites are
illustrated by an arrow; the arrow in (E) refers to the predicted signal peptide cleavage site for rh161.1. Boxed amino acids represent the ELRCXC-like motif. Amino
acids conserved in all of the aligned proteins are indicated by an asterisk. RhUL146a is aligned with the chemokine ligand 1 (CXCL1/GRO) of rhesus macaque
(Macaca mulatta) (accession number NP_001028050).
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RhCMVisolate (22659) (accession number EU130540) that had
undergone a limited but unknown number of passages in culture
(Alcendor et al., 1993; Barry et al., 1996). Therefore, the ULb′
structure presented in Fig. 1 likely reflects that of wild-type
RhCMV.
Flanking these novel genes in segment E are three other alpha
chemokine-like ORFs found only in the 68-1 RhCMV strain:
UL146 (accession number AAO40076, not annotated in 68-1;
Penfold, personal communication), UL147 (annotated as rh158
in 68-1), and rh161.2 (Fig. 1). ORF rh161.2, originally described
in 68-1 as rh161, shares 39% identity with rh161.1 (Fig. 2E). The
conserved regions of rh161.1 and 161.2 include a consensus
alpha chemokine motif (EQRCQC in rh161.1 and EKE/HCPC
in rh161.2), in addition to 7 other cysteine residues. It is likely
that rh161.1 and rh161.2 arose via a duplication event, and the
nomenclature assigned herein reflects this. Although sequence
identity of rh161.2 with alpha chemokines is limited, Phyre
analysis revealed some structural homology to interleukin-8
around the CXC motif. While functional studies remain to beTable 1
ORFs in the ULb′ region of RhCMVCNPRC
Strand a RhCMV ORF HCMV ORF From To Length (aa) Exon
C None None 1 747 249
None None 2 793 264
None None 3 761 253
None None 9459 9812 118
None None 11411 11848 146
None None 12311 12619 102
W RhUL128 UL128 722 1175 150 3
1261 1398 46 2
1487 1626 47 1
rh157.4 NH 1628 2359 243
RhUL130 UL130 2481 2762 93
RhUL131a UL131A 2759 3020 86 2
3103 3359 86 1
RhUL132 (rh160) UL132 3403 4068 221
RhUL148 (rh159) UL148 4134 5114 326
RhUL147 (rh158) UL147 5319 5780 153
RhUL146 UL146 5831 6175 114
RhUL146aE NH 6252 6348 31 2
6425 6615 63 1
RhUL146bE NH 6738 7064 108
rh161.1E NH 7188 7520 110
rh161.2 NH 7602 8117 157–171
RhUL145 (rh162) UL145 8202 8507 101
RhUL144 (rh163) UL144 8925 9440 171
RhUL141 (rh164) UL141 9643 10935 430
rh165 NH 11396 11827 143
rh166 NH 11872 12396 174
rh167 NH 12527 13030 167
NH: no homologue in HCMV.
E: ORFs found in segment E of RhCMVCNPRC and RhCMV22659 (see Fig. 1).
*: CNPRC 1/CNPRC 2/22659 (see Fig. 2A).
a C=coding strand (left-to-right transcription); W=complementary strand (right-tperformed, it appears that wild-type RhCMV encodes up to six
alpha chemokine-like proteins in the ULb′ region.
Comparison of wild-type RhCMVULb′ sequences with those
from passaged strains revealed a high sequence conservation in
most ORFs (Table 1), mirroring what is generally found between
HCMV clinical and tissue culture-passaged isolates. Exceptions
to this in RhCMVappear to be limited to the alpha chemokine-
like genes. UL146 in wild-type variants were as much as 43%
divergent from UL146 in 68-1. UL146 in HCMV clinical
isolates can also diverge by as much as 60% (Arav-Boger et al.,
2006; Hassan-Walker et al., 2004; Lurain et al., 2006; Prichard
et al., 2001). Rh161.2 in wild-type RhCMV was also highly
variable from that in 68-1 (72–100% aa identity) in addition
to differing in length by 12 to 25 aa at the carboxyl terminus
(Fig. 2F). One of the breakpoints for DNA sequence
discontinuity between RhCMV68-1 and RhCMVCNPRC (nucleo-
tide 167312 in 68-1, Fig. 1) is immediately downstream of the
reported stop codon for rh161 in 68-1. Therefore, it appears that
the rearrangement of the 68-1 genome eliminated the carboxy
terminal 12–25 aa of this particular ORF, and generated a novelID with RhCMV ID with HCMV Comment
100 44 Homology between aa 15 and 134
of HCMV UL128
100 14 aa longer than 180.92 rh157.4




99 30 Homology between aa 14 and 264
of HCMV UL148
96 36 CXC motif
92/57/100⁎ 27/33/27 CXC motif;
CXC motif
CXC motif
CXC motif; possible tandem duplication
of rh161.2 (see text)
72–100 CXC motif; annotated as rh161 in 68–1;
12–25 aa longer than rh161 of 68-1;




100 Possible tandem duplication of rh166
100 Possible tandem duplication of rh166
98 Possible tandem duplication of rh165
o-left transcription).
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hibited considerable sequence divergence in the amino terminus
(54%) (data not shown), similar to what has been reported for
HCMV UL147 (Arav-Boger et al., 2006; Lurain et al., 2006).
Further analysis is required to confirm this interpretation. High
sequence divergence was similarly prevalent in the 3 novel
ORFs in segment E. Wild-type sequences diverged from each
other by 10% for rh161.1, 44% for RhUL146b, and 46% for
RhUL146a (Figs. 2E, D, and B). RhUL146b was also dis-
tinguished by differences in the length of the predicted protein.
The tandemly arrayed rh165 and rh166 ORFs appear to have
arisen from a single ancestral gene because the wild-type
RhCMV sequences exhibit 39% identity with each other. Both
wild-type rh165 and 166 are 100% identical to their 68-1 homo-
logues. Phyre analysis does not indicate structural homologyFig. 3. Proposed splicing of the RhUL130 and rh157.4 ORF. (A) A putative intron f
amino acids of the unspliced rh157.4 ORF are underlined. *: Translation stop codon. (
accession number NP_612749) with the site of the proposed exon/exon boundary inwith any viral or cellular proteins. The annotation for RhCMV68-1
rh166 indicates that the sequence is “similar to UL133” of
HCMV (Hansen et al., 2003), however the wild-type rh166 does
not share any evident sequence homology with HCMV UL133.
Only a weak homology to chimp CMV (CCMV) UL138 (36%
identity to aa 25–50 of NP_612763) is present in rh166 (data not
shown).
Wild-type RhCMV rh157.4 (no homologue in HCMV) and
RhUL130 are both homologous to HCMV UL130 within the
carboxy terminal two-thirds and the amino terminal one-third of
the two ORFs, respectively. The wild-type rh157.4 encodes an
additional 14 aa at the carboxyl terminus that are not present in
the rh157.4 ORF of RhCMV180.92. One of the rh157.4 clones
also contains an internal 16 aa deletion. Apart from these
changes, rh157.4 of RhCMV180.92 and wild-type RhCMV areor a spliced RhUL130 and rh157.4 fusion is indicated by shading. The first five
B) Alignment of the RhUL130/rh157.2 fusion with chimp CMVUL130 (CCMV;
dicated by the arrow.
186 K.L. Oxford et al. / Virology 373 (2008) 181–188100% identical. Phyre analysis does not reveal any significant
homologies with viral or cellular proteins. Potential splice donor
and acceptor sites were identified (GT and AG, respectively),
which, if utilized, would generate a fusion of rh157.4 and
RhUL130 (Fig. 3). The splice acceptor site is located 13 aa
before the putative ATG codon of 157.4, seven of which are
identical to CCMV UL130. Utilization of these splice sites, as
well as those proposed for RhUL128, RhUL131a, and
RhUL146a, remains to be confirmed.
Discussion
This report redefines the coding potential of the ULb′ region
of RhCMVby the identification of three novel alpha chemokine-
like ORFswithinmultiple RhCMVvariants that have never been
passed in culture. The genomic structure of ULb′ is conserved
between RhCMVs currently circulating amongst CNPRC
macaques and a viral isolate (22659) first passed in culture
almost 20 years ago. This evidence strengthens the interpretation
that the order of genes in Fig. 1 accurately represents the coding
content of ULb′ in wild-type RhCMV. The ULb′ region of
RhCMV, like the homologous region in HCMV, is uniquely
unstable and can accumulate mutations and deletions even after
brief passage in vitro. The basis for the genomic instability
within RhCMV ULb′ remains unknown. There are no obvious
repeat or secondary structures, or distinct changes in base
composition that might account for the high propensity to
undergo rearrangements. Given the extent of the gene loss in
many HCMV and RhCMV strains after passage in culture, it is
clear that these ORFs are not required for replication in cultured
fibroblasts. However, the absence of ULb′ rearrangements in
RhCMV 22659, which was propagated initially on MRC-5,
human diploid fibroblasts, indicates that limited growth on non-
host cells does not necessarily lead to genomic rearrangements.
Reported in vitro functions for HCMV ULb′-encoded ORFs
strongly indicate that their functions contribute to cell tropism
and viral pathogenesis and/or escape from host viral clearance
mechanisms during establishment and maintenance of persis-
tence. Thus it would appear that growth on cell types susceptible
to productive infection in vivo should be used to propagate wild-
type virus in vitro.
CMV species co-evolved with their cognate hosts during the
radiation and speciation of mammals resulting in similar but not
identical repertoires of viral immune modulating genes. Co-
evolution of RhCMV with its macaque host appears to have
selected for a heavy viral investment in alpha chemokine-like
proteins. The presence of six ORFs in RhCMV with homology
to alpha chemokines, versus only two in HCMV and three in
CCMV, suggest that each virus has distinct evasion strategies
against host antiviral mechanisms. Although the six RhCMV
ORFs share sequence motifs and or structural characteristics
with alpha chemokines, in vitro and in vivo studies are needed
to determine the roles of these ORFs in RhCMV natural history.
Depending on which amino acids flank the CXC motif,
chemokine engagement of its receptor can be agonistic or
antagonistic for signaling (Loetscher and Clark-Lewis, 2001;
Moser et al., 1993). The promiscuity of chemokine/receptorinteractions allows agonists of certain immune cells, such as
TH1 cells, to be antagonists of others, such as TH2 cells. The
presence of these ORFs in RhCMV may enable a subtle and
highly refined modulation of host cell trafficking and activation
during the earliest stage of RhCMV infection.
It is especially intriguing that these same ORFs are hyper-
variable in circulating strains of both RhCMVand HCMV. Both
RhCMV and HCMV UL146 exhibit considerable sequence
divergence, yet for HCMV UL146, functionality is retained
despite the divergence (Prichard et al., 2001). HCMV UL146
binds to IL-8 receptors and induces neutrophil chemotaxis,
calcium flux, and degranulation (Penfold et al., 1999), potential-
ly facilitating viral dissemination. All three wild-type RhCMV
UL146 variants maintained the ELRCXC motif required for
chemokine receptor binding and activity (Clark-Lewis et al.,
1991) and four other cysteine residues, implying preservation of
tertiary structure. In addition to UL146, RhCMVCNPRC also
encodes the HCMVUL147 homologue (rh158) and contains the
conserved CXC motif. However, HCMV UL147 does not bind
to the CXC receptor, and no chemokine-like function has been
observed (Saederup andMocarski, 2002). It should be noted that
there is no rapid genetic drift of HCMV UL146 and 147
sequences in vivo. These sequences remain invariant when
HCMV virus is repeatedly isolated from individual patients over
time (Lurain et al., 2006). Partial clones suggest a similarly high
amount of sequence divergence within RhCMV UL147.
Together with the high variability, RhUL146a, RhUL146b,
rh161.2, RhUL146 and RhUL147 are linked by an apparent
involvement in targeting a similar pathway(s). Why the putative
viral-mediated modulation of innate cell trafficking and
signaling would be associated with profound sequence diversity
remains a mystery.
Sequence analysis of cellular proteins has shown that host
defense ligands and their receptors undergo the most rapid
divergence compared to other cellular protein families. In addi-
tion, this diversity may arise from species-specific molecular
mimicry by microbes (Murphy, 1993). Thus, it may be hypoth-
esized that diversity found in both host immune defense proteins
and viral immune modulatory proteins arises from a stepwise
competition for fitness by each organism, where viral hijacking
of cellular genes is a common theme.
Additional chemokine-like ORFs in wild-type RhCMV
implies that viral modulation of innate immune responses is an
especially critical mechanism during the earliest stage of virus
infection. Evidence for the presence of multiple chemokines
from this and other studies strengthens the hypothesis that
RhCMV alters numerous host antiviral responses that cumula-
tively and ultimately favor viral dissemination and lifelong
persistence. Additional studies are required to elucidate specific
pathways targeted by these immunomodulatory proteins to
subvert host immunity and favor viral persistence in an immune
competent host.
Sequence homologues of HCMV and CCMV ULb′ ORFs
that were not identified in any RhCMV isolate (CNPRC, 22659,
68-1, and 180.92) include UL133, 135, 136, 139, 140, 142,
147a, 150, 151, and possibly 138. However, functional
homologues may be encoded by the numerous ORFs found
187K.L. Oxford et al. / Virology 373 (2008) 181–188only in RhCMV (rh157.4, RhUL146a, RhUL146b, rh161.1,
rh161.2, rh165-167). Together with an absence of UL18, the
lack of a UL142 homologue means that RhCMV does not
appear to encode any of the MHC type I homologues found in
HCMV. RhCMV does encode other ORFs implicated in HCMV
attenuation of natural killer cell function, including UL40, 141,
and a duplication of UL83, although functional studies have not
yet been performed. Another HCMV ORF missing from
RhCMV, UL138, has recently been implicated in the establish-
ment and maintenance of latency in CD34+ myeloid progenitor
cells. It is not known at this time whether RhCMV infects the
CD34+ cell lineage in rhesus macaques and thus whether it
encodes a functional homologue to HCMV UL138 or an
analogous ORF that promotes latency in a different cellular
reservoir. The presence of these additional ORFs in both CCMV
and HCMV strongly implies that they conferred some selective
advantage to the great ape CMVs in their respective hosts.
In future studies of the rhesus macaque/RhCMV model, the
use of clinical strains of RhCMV possessing the entire ULb′
region will enhance the understanding of host–virus dynamics
involving tropism, latency, and pathogenesis. Moreover, a
thorough comparison between the entire genomes of wild-type
and laboratory passaged RhCMVmay reveal potentially deleted
non-core ORFs in regions other than ULb′.
Materials and methods
Oral swabs were collected from RhCMV-seropositive rhesus
macaques by running a Dacron swab along the gumlines and
buccal pouch and allowing the swab to absorb a saturating amount
of saliva (∼0.2 ml). Viral DNAwas purified from the unclarified
swab samples according to previously published methods (Huff
et al., 2003). The ULb′ region of RhCMV was amplified in
overlapping segments by PCR (Taq or Pfu) using primers
corresponding to the sequences published for RhCMV strains
68-1 and 180.92 (accession numbers AY186194 and DQ120516,
respectively) (Hansen et al., 2003; Rivailler et al., 2006). The
amplicons were cloned using the pCR2.1 TA cloning vector
(Invitrogen Corporation, Carlsbad, CA). Every ORF in Fig. 1 was
analyzed with amplicons from at least two different animals and a
clinical isolate, 22659 (Alcendor et al., 1993; Barry et al., 1996).
Multiple independent clones from each of three animals were
sequenced for the segment E genes. DNA sequences from
overlapping clones were aligned using CHAOS-DIALIGN
(Brudno et al., 2003), translation products were located with the
ExPASy proteomics server (Gasteiger et al., 2003), protein
sequences were aligned using the ClustalW multiple sequence
alignment program (www.ebi.ac.uk/clustalw/# (Thompson et al.,
1994)), relationships to other proteins were identified using the
NCBI BLAST programs (www.ncbi.nlm.nih.gov/BLAST/), sig-
nal peptide cleavage siteswere identified using SignalP 3.0 (www.
cbs.dtu.dk/services/SignalP/ (Emanuelsson et al., 2007)), and the
Protein Homology/Analogy Recognition Engine (Phyre) was
used to analyze proteins for structural similarities to other proteins
(Kelley et al., 2000).
The accession numbers for the RhCMV sequences are
EF990255, EF990256, EU003822, and EU130540.Note added in proof
The proposed splice site for the RhCMV UL130/rh157.4
ORFs (Fig. 3) has been confirmed by reverse transcription/PCR
analysis using RNA isolated from cells infected with RhCMV
strain 22659.
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